University of Essex
Colchester, Essex, CO4 3SQ, United Kingdom
NCT Number: NCT07516600
This study investigates whether the design of weblinks in digital vaccination invitations affects how much people trust the message and their willingness to book an appointment. Researchers compare a standard third-party weblink used by the NHS ("accurx.thirdparty.nhs.uk/r/aafwaczmd5") with an improved, more transparent weblink (https://vaccine-booking.nhs.uk).
The study tests the hypothesis that the improved link will be perceived as more trustworthy and easier to read than the standard link. Further, the study tests whether participants would be more likely to correctly identify the sender and would be more willing to book a vaccine when shown the improved link.
To test these effects, the investigators planned to conduct a study with 600 participants from the United Kingdom and 600 from the United States. Participants will be randomly assigned to view one of the two hypothetical email versions. UK participants will see an email that appears to be from the NHS. US participants will see an email from a fictitious pharmacy (Pharma-US).This research aims to provide evidence on how to design more trustworthy digital health communications when recipients are asked to click a weblink.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Colchester, Essex, CO4 3SQ, United Kingdom
This randomised experimental study investigates how weblink design influences the perceived trustworthiness of digital health communications. As digital invitations (e.g., emails and SMS) have become standard for public health initiatives such as vaccination programmes, the use of third-party or disfluent (hard-to-read) web links may inadvertently undermine trust.
Study Protocol and Intervention Participants will be randomly allocated to one of two experimental conditions. In both conditions, participants will view a hypothetical email invitation for a COVID-19 booster vaccine. The content of the emails will remain identical except for the format of the embedded booking link: Control Condition: Features the "accurx" web link (accurx.thirdparty.nhs.uk/r/aafwaczmd5), a third-party format previously used in COVID-19 vaccination invitations by the National Health Service (NHS) in the UK. Experimental Condition: Features an improved, transparent - "clear" - weblink that was designed to be easier to read and clearly identifies the host organisation (e.g., https://vaccine-booking.nhs.uk). The UK and US respondents will see different hypothetical emails tailored to their country of residence: UK participants will see invitations sent from the NHS, while US participants will see invitations from a fictitious pharmacy (Pharma-US). Unlike the UK, COVID-19 vaccination in the US was predominantly organised by local pharmacies.
Primary Hypotheses
The study is designed to test four primary hypotheses:
Measurement Following the presentation of the stimulus, participants will rate the emails on three 5-point Likert scales: trustworthiness (1: Very suspicious to 5: Very trustworthy), link fluency (1: Very difficult to 5: Very easy), and booking intention (1: Very unlikely to 5: Very likely). Host identification is assessed via a multiple-choice question with four options: the NHS, Pharma-US, Accurx, or "Not sure". The investigators aim to collect data from 600 participants from the UK and 600 from the US. Participants will be invited to complete the study via an online platform.
Data will be analysed using a within-subject analysis of variance (ANOVA) to examine the effects of link manipulation, with further robustness checks incorporating sociodemographic variables such as age, gender, and education. UK and US participants data will be analysed separately if needed. This study is conducted as part of a larger research project exploring the broader relationship between the trustworthiness of digital messages and national vaccination rates.
The study hypotheses, design, measures and analyses were preregistered before the start of data collection on a different platform (AsPredicted). This time stamped preregistration protocol is link as a document in this registration.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention involves presenting a digital COVID-19 booster vaccination invitation via email. Participants are randomly allocated to view one of two versions of the invitation to evaluate the impact of the weblink design on trust and behaviour. To ensure local relevance, the email content is adapted based on the participant's country of residence; participants in the United Kingdom see invitations sent from the NHS, while those in the United States see invitations from Pharma-US
Time frame: Immediately after intervention
Participants rated the perceived trustworthiness of the vaccination invitation email on a 5-point Likert scale, where 1 represents "Very suspicious" and 5 represents "Very trustworthy"
Time frame: Immediately after intervention
Participants rated their likelihood of booking a vaccine appointment based on the email invitation using a 5-point Likert scale ranging from 1 ("Very unlikely") to 5 ("Very likely")
Time frame: Immediately after intervention
Participants assessed the reading ease or fluency of the embedded weblink on a 5-point Likert scale, where 1 is "Very difficult" and 5 is "Very easy"
Time frame: Immediately after intervention
Participants were asked to identify the organisation that sent the communication by selecting one answer from a multiple-choice list of four options: the NHS, Pharma-US, Accurx, or Unclear/I don't know
University of Essex
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03587610
Vaccination
Le Mans, France
View Trial DetailsNCT01054053
Vaccination
Neufchâtel-en-Bray, France
View Trial DetailsNCT07007377
Flu, Flu-like Symptoms
São Paulo, Brazil
View Trial DetailsNCT04936776
Hematologic Diseases, Hemic and Lymphatic Diseases
New York, United States
View Trial Details